Reliv' International (OTC:RELV) Stock, Quote.Headers.trade-ideas

Reliv' International

Reliv' International Inc is a developer, manufacturer, and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management, and sports nutrition. The company sells its products throughout the United States and in Australia, Austria, Canada, France, Germany, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, the United Kingdom, and Asia, through an international network marketing system using independent distributors. It generates a majority of its revenue from the United States.

News

Penny Stocks

Pre-Market Outlook

Markets

Movers

Trading Ideas

ABIO

AEYE

AGFS

ALDX

ARPO

ASNA

ATOM

BCRX

BOMN

CDOR

CERC

CJJD

CNSP

CRDF

CRNC

CVGI

DLTR

DZSI

EDUC

ESEA

FLXN

FPRX

FTSI

GEOS

GMBL

GRNQ

IDYA

IOVA

IPWR

LIVE

MCEP

MIXT

NNBR

NWHM

ONCY

ORGO

PHAS

PLMR

RELV

SINT

SOHO

TCCO

TORC

USEG

VRML

WDAY

Gainers


	ARCA biopharma, Inc. (NASDAQ: ABIO) shares climbed 386.3% to close at $19.21 on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.


65 Biggest Movers From Yesterday

ALJJ

ATOS

BLIN

BPMX

CTRC

ELVT

IBIO

KTOV

LORL

MARK

RIOT

SAVA

SBSW

SRNE

TRCH

TSLX

YCBD

Gainers


	ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares rose 87.5% to $0.60 in pre-market trading after reporting Q2 results. ALJ Regional’s quarterly sales rose to $96.00 million from $87.996 million.


26 Stocks Moving in Monday&#39;s Pre-Market Session

ACEL

ALTG

APDN

APRN

BCEL

BXRX

CMRX

CODX

CREX

CRTX

CTEK

DKNG

FREQ

FTCH

GNFT

GNLN

GPRK

GROW

GSMG

Hollsys Automation Technologies INTERNATIONAL

HOLI

IMUX

INUV

IZEA

LEGH

LIQT

NEWR

NNVC

NPTN

OCUL

ONEW

OPRT

PRPL

PSTV

SGBX

SLGG

SNES

STON

TESS

THMO

TTNP

VTIQ

YTEN

Gainers


	Sorrento Therapeutics, Inc  (NASDAQ: SRNE) shares climbed 158% to close at $6.76 on Friday amid investor attention surrounding the company&#39;s STI-1499 coronavirus antibody.


70 Biggest Movers From Friday

RELIV INTL INC by Reliv International, Inc.

Reliv' International Inc

Reliv International Announced An Update To Its Plan To Suspend Its Obligations To File Periodic And Current Reports And Other Information With The SEC And Delist Its Common Stock From Trading On The Nasdaq As Previously Announced On October 19

Reliv' International (NASDAQ:<a class="ticker" href="/stock/RELV#NASDAQ">RELV</a>) reported quarterly losses of $(0.07) per share. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year. The company reported $8.70 million in sales this quarter. This is a 4.91 percent decrease over sales of $9.15 million the same period last year.

Earnings

Reliv' International Q3 EPS $(0.07) Up From $(0.09) YoY, Sales $8.70M Down From $9.15M YoY

Reliv International Entered Into $4M Term Loan Agreement With Enterprise Bank And Trust; Term Loan Is For Period Of 5 Years With Fixed Interest Rate Of 4.25%

WIIM

Reliv' International shares are trading lower after the company announced it would get delisted from the NASDAQ following the announcement of a 2000 to 1 stock split

Stock Split

Reliv International to Delist from the NASDAQ, Announces 2,000 for 1 Stock Split

Reliv' International (NASDAQ:<a class="ticker" href="/stock/RELV#NASDAQ">RELV</a>) reported quarterly losses of $(0.11) per share. This is a 50 percent increase over losses of $(0.22) per share from the same period last year. The company reported $8.00 million in sales this quarter. This is a 3.11 percent decrease over sales of $8.26 million the same period last year.

Reliv' International Q2 EPS $(0.11) Up From $(0.22) YoY, Sales $8.00M Down From $8.26M YoY

<h3>Gainers</h3>
<ul>
<li>ARCA biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abio#NASDAQ">ABIO</a>) shares climbed 386.3% to close at $19.21 on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.</li>
<li>Hexindai Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hx#NASDAQ">HX</a>) shares gained 170.8% to close at $1.30 after the company highlighted the launch of Xiaobai Miami, a membership-based social e-commerce mobile platform.</li>
<li>Aerpio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arpo#NASDAQ">ARPO</a>) surged 44.5% to close at $1.13. Aerpio Pharmaceuticals and Quantum Leap Healthcare reported an agreement to evaluate razuprotafib in the I-SPY COVID trial for the treatment of acute respiratory distress syndrome in COVID-19 patients.</li>
<li>PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) shares jumped 36.2% to close at $6.02 after the company announced FDA authorization to proceed with VANGARD, a potentially pivotal clinical trial to evaluate PB1046 as a treatment for hospitalized COVID-19 patients who are at high risk for rapid clinical deterioration and acute respiratory distress syndrome.</li>
<li>Live Ventures Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/live#NASDAQ">LIVE</a>) climbed 35.3% to close at $10.50.</li>
<li>Organogenesis Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orgo#NASDAQ">ORGO</a>) shares jumped 33.2% to close at $4.61.</li>
<li>Esports Entertainment Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmbl#NASDAQ">GMBL</a>) gained 27.5% to close at $5.42.</li>
<li>Simulations Plus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slp#NASDAQ">SLP</a>) gained 22.6% to close at $48.43 after the company received a new</li>
<li>grant award from the FDA for ophthalmic drug. Simulations Plus will replace TiVo Corpin the S&amp;P SmallCap 600 on Monday, June 1.</li>
<li>IDEAYA Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idya#NASDAQ">IDYA</a>) surged 22.6% to close at $9.40.</li>
<li>Diversified Healthcare Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dhc#NASDAQ">DHC</a>) shares gained 22.4% to close at $3.94. Diversified Healthcare Trust will replace FGL Holdings in the S&amp;P SmallCap 600 on Monday, June 1.</li>
<li>Technical Communications Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcco#NASDAQ">TCCO</a>) gained 22.1% to close at $3.10 after the company reported results for its second quarter.</li>
<li>AudioEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeye#NASDAQ">AEYE</a>) rose 19.4% to close at $8.63.</li>
<li>Target Hospitality Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/th#NASDAQ">TH</a>) gained 18.6% to close at $2.61 after reporting Q1 results.</li>
<li>Educational Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/educ#NASDAQ">EDUC</a>) jumped 17.6% to close at $7.94.</li>
<li>Condor Hospitality Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cdor#NYSE">CDOR</a>) gained 16.8% to close at $4.38.</li>
<li>Nabors Industries Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nbr#NYSE">NBR</a>) climbed 16.4% to close at $44.95.</li>
<li>FTS International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftsi#NYSE">FTSI</a>) shares gained 16.2% to close at $7.19.</li>
<li>Atomera Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atom#NASDAQ">ATOM</a>) rose 15.5% to close at $8.89.</li>
<li>Vermillion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrml#NASDAQ">VRML</a>) shares surged 15.3% to close at $3.25.</li>
<li>Palomar Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plmr#NASDAQ">PLMR</a>) gained 14.1% to close at $74.76. Palomar Holdings will replace LSB Industries in the S&amp;P SmallCap 600 on June 1.</li>
<li>Mid-Con Energy Partners, LP (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcep#NASDAQ">MCEP</a>) rose 13.7% to close at $2.65.</li>
<li>Flexion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flxn#NASDAQ">FLXN</a>) gained 12.8% to close at $11.65.</li>
<li>U.S. Energy Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/useg#NASDAQ">USEG</a>) jumped 12.8% to close at $6.60.</li>
<li>Aldeyra Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) gained 12.7% to close at $4.72.</li>
<li>Geospace Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/geos#NASDAQ">GEOS</a>) jumped 12.2% to close at $8.16.</li>
<li>Braemar Hotels &amp; Resorts, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhr#NYSE">BHR</a>) gained 11.9% to close at $3.65.</li>
<li>Dollar Tree, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dltr#NASDAQ">DLTR</a>) rose 11.6% to close at $97.64 after the company reported better-than-expected Q1 results.</li>
<li>DASAN Zhone Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dzsi#NASDAQ">DZSI</a>) rose 11.4% to close at $7.60.</li>
<li>Triumph Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgi#NYSE">TGI</a>) rose 11.4% to close at $9.11 after the company reported better-than-expected Q4 results.</li>
<li>Cardiff Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) climbed 10% to close at $2.53 after the company reported that the FDA has granted Fast Track designation to onvansertib for second-line treatment of KRAS-mutated colorectal cancer.</li>
<li>GAN Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gan#NASDAQ">GAN</a>) surged 9.8% to close at $18.10 after the company announced Codrish Gaming Group has engaged it as enterprise software platform provider to power new &#39;playlive!&#39; branded internet gambling business in Pennsylvania.</li>
<li>Sotherly Hotels Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soho#NASDAQ">SOHO</a>) shares gained 8.6% to close at $2.91.</li>
<li>Oncolytics Biotech Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oncy#NASDAQ">ONCY</a>) rose 7.8% to close at $2.48 after falling around 13% on Wednesday.</li>
<li>Workday, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wday#NASDAQ">WDAY</a>) rose 7.2% to close at $182.56 after the company announced better-than-expected Q1 sales. The company also announced separate partnerships with Microsoft and Salesforce.</li>
<li>Cerecor Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cerc#NASDAQ">CERC</a>) gained 7.1% to close at $2.9250 after the company reported the FDA clearance of IND for CERC-002 in COVID-19 induced ARDS.</li>
<li>Ideal Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipwr#NASDAQ">IPWR</a>) rose 6.2% to close at $2.22 after gaining around 7% on Wednesday.</li>
<li>resTORbio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/torc#NASDAQ">TORC</a>) gained 5.2% to close at $2.21 after the company initiated a study to evaluate if antiviral prophylaxis with RTB101 reduces the severity of COVID-19 in nursing home residents.</li>
<li>Yunji Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yj#NASDAQ">YJ</a>) shares rose 5.1% to close at $3.31. Yunji is expected to release Q1 results on June 3.</li>
<li>Lumber Liquidators Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ll#NYSE">LL</a>) rose 5% to close at $10.03 after the company reported better-than-expected Q1 earnings and named Charles Tyson as President and CEO.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Greenpro Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grnq#NASDAQ">GRNQ</a>) shares dipped 35.3% to close at $1.67 on Thursday. Greenpro shares jumped 212% on Wednesday after the company signed an agreement to acquire part of Millennium Sapphire.</li>
<li>China Jo-Jo Drugstores, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cjjd#NASDAQ">CJJD</a>) shares tumbled 24.8% to close at $2.52.</li>
<li>Hertz Global Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/htz#NYSE">HTZ</a>) fell 22.1% to close at $1.02 after jumping 136% on Wednesday.</li>
<li>Luckin Coffee Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lk#NASDAQ">LK</a>) fell 20.5% to close at $2.06 after gaining more than 21% on Wednesday.</li>
<li>Euroseas Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/esea#NASDAQ">ESEA</a>) dipped 19.1% to close at $2.75.</li>
<li>AgroFresh Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfs#NASDAQ">AGFS</a>) dipped 17.3% to close at $2.68.</li>
<li>Ascena Retail Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asna#NASDAQ">ASNA</a>) fell 16.5% to close at $1.95 after reporting a 45% decline in Q3 sales.</li>
<li>Cerence Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crnc#NASDAQ">CRNC</a>) fell 16.2% to close at $27.72.</li>
<li>Five Prime Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fprx#NASDAQ">FPRX</a>) dipped 15.7% to close at $5.01.</li>
<li>Townsquare Media, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tsq#NYSE">TSQ</a>) fell 15.5% to close at $4.35.</li>
<li>Boston Omaha Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bomn#NASDAQ">BOMN</a>) dipped 15.5% to close at $16.41 after announces a $50 million share common stock offering.</li>
<li>Reliv&#39; International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/relv#NASDAQ">RELV</a>) fell 14.6% to close at $3.50.</li>
<li>The New Home Company Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nwhm#NYSE">NWHM</a>) dipped 14.6% to close at $3.23.</li>
<li>VirnetX Holding Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vhc#NYSE">VHC</a>) fell 14.5% to close at $6.45.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) dropped 14.3% to close at $32.66 after the company announced a $500 million proposed public offering of common stock.</li>
<li>Plantronics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plt#NYSE">PLT</a>) dropped 14.2% to close at $12.53 after the company reported preliminary Q4 earnings results.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) shares dropped 14% to close at $0.7165 after climbing over 25% on Wednesday.</li>
<li>NN, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nnbr#NASDAQ">NNBR</a>) fell 13.7% to close at $4.14.</li>
<li>Commercial Vehicle Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvgi#NASDAQ">CVGI</a>) dropped 13.2% to close at $2.53.</li>
<li>Dorian LPG Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lpg#NYSE">LPG</a>) shares declined 12.7% to close at $7.92. Dorian LPG released Q4 earnings on Wednesday.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsp#NASDAQ">CNSP</a>) fell 12.7% to close at $2.41. CNS Pharma reported sponsored research deal with the University Of Texas MD Anderson Cancer Center for potential cancer treatment technologies.</li>
<li>HP Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hpq#NYSE">HPQ</a>) fell 12.3% to close at $15.01. HP reported better-than-expected earnings for its fiscal second quarter, while sales missed expectations. The company also issued weak earnings guidance for the third quarter.</li>
<li>Viela Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vie#NASDAQ">VIE</a>) fell 11.5% to close at $45.62 after the company reported pricing of public offering of common stock.</li>
<li>BioCryst Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcrx#NASDAQ">BCRX</a>) fell 10.7% to close at $4.4950. BioCryst Pharma priced its 18.7 million share offering at $4.50 per share.</li>
<li>Cooper-Standard Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cps#NYSE">CPS</a>) shares fell 8% to close at $11.81.</li>
<li>MiX Telematics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mixt#NASDAQ">MIXT</a>) dropped 6% to close at $8.61 after reporting preliminary results for its fourth quarter.</li>
</ul>

<h3>Gainers</h3>
<ul>
<li>ALJ Regional Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aljj#NASDAQ">ALJJ</a>) shares rose 87.5% to $0.60 in pre-market trading after reporting Q2 results. ALJ Regional&rsquo;s quarterly sales rose to $96.00 million from $87.996 million.</li>
<li>Elevate Credit, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elvt#NYSE">ELVT</a>) rose 79% to $2.81 in pre-market trading.</li>
<li>cbdMD, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ycbd#NASDAQ">YCBD</a>) rose 57.7% to $1.53 in pre-market trading following strong Q2 earnings.</li>
<li>Sorrento Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srne#NASDAQ">SRNE</a>) rose 35% to $9.12 in pre-market trading. Sorrento shares jumped 158% on Friday after the company said its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in anin vitrovirus infection experiment at a very low antibody concentration.</li>
<li>iBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibio#NASDAQ">IBIO</a>) rose 25% to $1.85 in pre-market trading after gaining over 24% on Friday.</li>
<li>Bridgeline Digital, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blin#NASDAQ">BLIN</a>) rose 24.8% to $1.96 in pre-market trading. Bridgeline Digital shares surged 27% on Friday after reporting Q2 earnings.</li>
<li>Kitov Pharma Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktov#NASDAQ">KTOV</a>) rose 19.8% to $0.5882 in pre-market trading after gaining around 7% on Friday.</li>
<li>Loral Space &amp; Communications Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lorl#NASDAQ">LORL</a>) rose 18.2% to $20 in pre-market trading.</li>
<li>Chesapeake Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chk#NYSE">CHK</a>) rose 15.9% to $12.50 in pre-market trading after jumping 24% on Friday.</li>
<li>Remark Holdings, Inc.. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mark#NASDAQ">MARK</a>) shares rose 15.4% to $1.50 in pre-market trading after falling over 6% on Friday.</li>
<li>Cassava Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sava#NASDAQ">SAVA</a>) rose 12.3% to $2.38 in pre-market trading. Cassava Sciences shares dipped 74% on Friday after the company announced the results from its Phase 2b study of PTI-125 in Alzheimer&#39;s disease did not meet the primary endpoint.</li>
<li>Aurora Cannabis Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acb#NYSE">ACB</a>) shares rose 11.6% to $12.50 in pre-market trading. Aurora Cannabis shares jumped 69% on Friday after the company reported a rise in Q3 sales.</li>
<li>Vir Biotechnology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vir#NASDAQ">VIR</a>) rose 11.2% to $33.76 in pre-market trading. Vir Biotechnology announced identification and characterization of a potential therapeutic COVID-19 antibody by Vir Biotechnology published in the journal Nature.</li>
<li>Riot Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) shares rose 10.6% to $2.30 in pre-market trading after dropping 9% on Friday.</li>
<li>TPG Specialty Lending, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tslx#NYSE">TSLX</a>) rose 10.2% to $18.91 in pre-market trading.</li>
<li>Camping World Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cwh#NYSE">CWH</a>) shares rose 9.7% to $17.40 in pre-market trading after gaining around 9% on Friday.</li>
<li>First Majestic Silver Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ag#NYSE">AG</a>) rose 9.6% to $9.69 in pre-market trading. First Majestic Silver shares climbed 12% on Friday after the company reported Q1 earnings results.</li>
<li>Sibanye Stillwater Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbsw#NYSE">SBSW</a>) rose 8.9% to $8.57 in pre-market trading after jumping over 10% on Friday.</li>
<li>Silvercorp Metals Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/svm#NYSE">SVM</a>) rose 7.5% to $4.87 in pre-market trading. Silvercorp Metals and Guyana Goldfields entered into an amending agreement.</li>
</ul>

Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Centric Brands Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctrc#NASDAQ">CTRC</a>) fell 36.2% to $0.60 in pre-market trading after the company filed for Chapter 11 bankruptcy protection.</li>
<li>Atossa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atos#NASDAQ">ATOS</a>) fell 17.7% to $1.40 in pre-market trading.</li>
<li>Torchlight Energy Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trch#NASDAQ">TRCH</a>) shares fell 15.1% to $0.3652 in pre-market trading after surging more than 48% on Friday.</li>
<li>BioPharmX Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bpmx#NYSE">BPMX</a>) fell 11.8% to $0.4970 in pre-market trading. BioPharmX disclosed that its 1-for-12 reverse stock split merger transaction is expected to close on May 18, 2020.</li>
<li>TransAtlantic Petroleum Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tat#NYSE">TAT</a>) shares fell 9.2% to $0.2002 in pre-market trading.</li>
<li>Reliv&#39; International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/relv#NYSE">RELV</a>) fell 8.7% to $3.38 in pre-market trading. Reliv&#39; International shares jumped around 17% on Friday after reporting Q1 results.</li>
<li>ICICI Bank Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ibn#NYSE">IBN</a>) fell 6.5% to $7.91 in pre-market trading.</li>
</ul>

26 Stocks Moving in Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Sorrento Therapeutics, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srne#NASDAQ">SRNE</a>) shares climbed 158% to close at $6.76 on Friday amid investor attention surrounding the company&#39;s STI-1499 coronavirus antibody.</li>
<li>Aurora Cannabis Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acb#NYSE">ACB</a>) gained 68.7% to close at $11.20 after reporting a rise in its Q3 sales.</li>
<li>Torchlight Energy Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trch#NASDAQ">TRCH</a>) shares climbed 48.3% to close at $0.43 after dropping over 21% on Thursday.</li>
<li>Alta Equipment Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/altg#NYSE">ALTG</a>) climbed 35.3% to close at $5.60 after the company reported Q1 results.</li>
<li>AgroFresh Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfs#NASDAQ">AGFS</a>) jumped 30.7% to close at $2.68.</li>
<li>Regional Management Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rm#NYSE">RM</a>) gained 30% to close at $15.63. BMO Capital upgraded Regional Management from Market Perform to Outperform and raised the price target from $14 to $29.</li>
<li>Bridgeline Digital, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blin#NASDAQ">BLIN</a>) gained 26.6% to close at $1.57 following Q2 results. Bridgeline Digital swung to earnings of $0.33 per share, versus a year-ago loss of $39.93 per share.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) gained 25.3% to close at $4.3400.</li>
<li>Chesapeake Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chk#NYSE">CHK</a>) shares gained 23.9% to close at $10.79.</li>
<li>Power REIT (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pw#NYSE">PW</a>) rose 23.8% to close at $19.80 after the company announced the acquisition of a 3 acre property in York County, Maine for $1,000,000 through a newly formed wholly owned subsidiary.</li>
<li>Esquire Financial Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/esq#NASDAQ">ESQ</a>) climbed 23% to close at $14.39.</li>
<li>Glory Star New Media Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsmg#NASDAQ">GSMG</a>) gained 22.5% to close at $4.35.</li>
<li>J. C. Penney Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jcp#NYSE">JCP</a>) gained 21.2% to close at $0.2363 after the company made a $17 million interest payment due May 7th, on the last day of its 5-day grace period, May 14th.</li>
<li>Vermillion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrml#NASDAQ">VRML</a>) rose 21.2% to close at $2.63 after reporting Q1 results.</li>
<li>Aldeyra Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) jumped 20% to close at $4.50.</li>
<li>Cortexyme, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crtx#NASDAQ">CRTX</a>) rose 19.9% to close at $55.01.</li>
<li>GeoPark Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gprk#NYSE">GPRK</a>) gained 18.6% to close at $7.99.</li>
<li>Fortuna Silver Mines Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsm#NYSE">FSM</a>) gained 17.9% to close at $3.96. Fortuna Silver Mines reported a Q1 net loss of $4.5 million.</li>
<li>Coeur Mining, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cde#NYSE">CDE</a>) gained 17.8% to close at $5.10.</li>
<li>OneWater Marine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onew#NASDAQ">ONEW</a>) rose 16.7% to close at $14.00.</li>
<li>Reliv&#39; International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/relv#NASDAQ">RELV</a>) shares jumped 16.7% to close at $3.70 following Q1 results. Reliv&#39; International posted Q1 earnings of $0.36 per share, up from $0.13 per share in the year-ago period.</li>
<li>China Distance Education Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dl#NYSE">DL</a>) gained 15.9% to close at $7.23.</li>
<li>Legacy Housing Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/legh#NASDAQ">LEGH</a>) rose 15.8% to close at $11.79 following upbeat Q1 results.</li>
<li>Atreca, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcel#NASDAQ">BCEL</a>) surged 15.7% to close at $19.13 after reporting Q1 results.</li>
<li>DraftKings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dkng#NASDAQ">DKNG</a>) gained 15.5% to close at $29.23 after reporting Q1 results.</li>
<li>Greenlane Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnln#NASDAQ">GNLN</a>) rose 15% to close at $2.61.</li>
<li>Frequency Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/freq#NASDAQ">FREQ</a>) gained 14.6% to close at $19.47.</li>
<li>Canopy Growth Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NYSE">CGC</a>) rose 14.4% to close at $15.86, potentially in sympathy with Aurora Cannabis following the company&#39;s Q3 results.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) gained 14.4% to close at $6.88.</li>
<li>Accel Entertainment, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acel#NYSE">ACEL</a>) shares rose 14.3% to close at $8.29.</li>
<li>MarineMax, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hzo#NYSE">HZO</a>) shares surged 14.3% to close at $16.16.</li>
<li>Oportun Financial Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oprt#NASDAQ">OPRT</a>) shares surged 13.8% to close at $6.84 after reporting an 18% rise in Q1 revenue.</li>
<li>Purple Innovation, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prpl#NASDAQ">PRPL</a>) shares climbed 12.9% to close at $12.94 after the company reported pricing of upsized secondary public offering of Class A common stock.</li>
<li>New Relic Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newr#NYSE">NEWR</a>) shares gained 9.6% to close at $63.89 after the company reported better-than-expected Q4 results.</li>
<li>Regis Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rgs#NYSE">RGS</a>) gained 9.3% to close at $8.85.</li>
<li>StoneMor Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ston#NYSE">STON</a>) shares rose 9.1% to close at $0.6380 after the company swung to a Q1 profit of $0.10 per share, versus a year-earlier loss of $0.59 per share.</li>
<li>Yield10 Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yten#NASDAQ">YTEN</a>) gained 8.3% to close at $5.24 after the company reported Q1 results. The company also secured regulatory permits for the US and Canadian Sites and announced plans for 2020 field test program in Camelina and Canola.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Cassava Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sava#NASDAQ">SAVA</a>) shares tumbled 73.9% to close at $2.12 on Friday after the company announced the results from its Phase 2b study of PTI-125 in Alzheimer&#39;s disease did not meet the primary endpoint.</li>
<li>Creative Realities, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crex#NASDAQ">CREX</a>) dropped 32.8% to close at $2.89 after the company filed for a mixed shelf offering of up to $50 million. The company also reported Q1 sales results down from last year.</li>
<li>Applied DNA Sciences, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apdn#NASDAQ">APDN</a>) fell 27% to close at $11.11 after the company reported weaker-than-expected results for its second quarter. The company&rsquo;s shares jumped 71% on Thursday after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.</li>
<li>Canaan Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/can#NASDAQ">CAN</a>) dipped 26.5% to close at $4.39.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) fell 25.5% to close at $1.67 after the company reported worse-than-expected Q1 results.</li>
<li>CynergisTek, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctek#NYSE">CTEK</a>) dropped 25% to close at $1.56 after reporting Q1 results.</li>
<li>ThermoGenesis Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thmo#NASDAQ">THMO</a>) shares declined 24.6% to close at $8.34 following Q1 results.</li>
<li>Co-Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/codx#NASDAQ">CODX</a>) shares fell 22.9% to close at $17.07 after reporting Q1 results.</li>
<li>Super League Gaming, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slgg#NASDAQ">SLGG</a>) dropped 20% to close at $3.27 after the company posted a wider loss for its first quarter.</li>
<li>ADDvantage Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aey#NASDAQ">AEY</a>) fell 19.8% to close at $1.78 following Q2 results. Addvantage Technologies posted a Q2 loss of $1.41 per share.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttnp#NASDAQ">TTNP</a>) shares dipped 19.1% to close at $0.2750.</li>
<li>NanoViricides, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nnvc#NYSE">NNVC</a>) shares tumbled 16.7% to close at $9.63.</li>
<li>Inuvo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/inuv#NYSE">INUV</a>) fell 16.2% to close at $0.3322 after reporting a Q1 loss of $0.05 per share.</li>
<li>NantKwest, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nk#NASDAQ">NK</a>) shares tumbled 15.4% to close at $4.3550. Nantkwest announced plans for a Phase 2, randomized, open-label study to evaluate the efficacy and safety of a combination immunotherapy: NantKwest&#39;s PD-L1 t-haNK, ImmunityBio&#39;s N-803, and aldoxorubicin HCI plus standard of care, versus standard-of-care chemotherapy for first- and second-line treatment of locally advanced or metastatic pancreatic cancer.</li>
<li>Plus Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstv#NASDAQ">PSTV</a>) fell 15% to close at $1.81 following Q1 results.</li>
<li>LiqTech International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/liqt#NASDAQ">LIQT</a>) shares dipped 14.2% to close at $5.09.</li>
<li>Genfit SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnft#NASDAQ">GNFT</a>) fell 13.9% to close at $5.75 after dropping over 6% on Thursday.</li>
<li>AIM ImmunoTech Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aim#NYSE">AIM</a>) dipped 13% to close at $2.56.</li>
<li>Myomo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/myo#NYSE">MYO</a>) shares slipped 12.9% to close at $3.73.</li>
<li>VectoIQ Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtiq#NASDAQ">VTIQ</a>) shares fell 12.3% to close at $22.62 after dipping 15% on Thursday.</li>
<li>NeoPhotonics Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nptn#NYSE">NPTN</a>) dropped 12% to close at $7.67.</li>
<li>Viad Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vvi#NYSE">VVI</a>) shares tumbled 12% to close at $14.65. Viad reported Q1 preliminary sales of $306 million.</li>
<li>AudioEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeye#NASDAQ">AEYE</a>) shares dropped 11.7% to close at $7.75 after reporting Q1 results.</li>
<li>Chimerix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmrx#NASDAQ">CMRX</a>) fell 11.7% to close at $3.18.</li>
<li>Farfetch Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) fell 11.3% to close at $14.10 after the company reported worse-than-expected Q1 sales results.</li>
<li>Blue Apron Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aprn#NYSE">APRN</a>) dropped 11.2% to close at $7.81.</li>
<li>IZEA Worldwide, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izea#NASDAQ">IZEA</a>) fell 11% to close at $0.6269 after the company reported weaker-than-expected Q1 results.</li>
<li>U.S. Global Investors, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grow#NASDAQ">GROW</a>) dropped 10.6% to close at $1.85 after reporting Q3 results.</li>
<li>Hollysys Automation Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holi#NASDAQ">HOLI</a>) fell 9.6% to close at $12.73 after reporting downbeat Q3 results.</li>
<li>TESSCO Technologies Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tess#NASDAQ">TESS</a>) dipped 9.4% to close at $4.36.</li>
<li>Immunic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imux#NASDAQ">IMUX</a>) dropped 8.6% to close at $9.85.</li>
<li>Armstrong Flooring, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/afi#NYSE">AFI</a>) shares slipped 7.1% to close at $2.34.</li>
<li>SG Blocks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgbx#NASDAQ">SGBX</a>) shares fell 7.1% to close at $2.37 after the company reported a wider Q1 loss.</li>
</ul>

<h3>Gainers</h3>
<ul>
<li>Sorrento Therapeutics, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srne#NASDAQ">SRNE</a>) shares jumped 88.1% to $4.9290 amid investor attention surrounding the company&#39;s STI-1499 coronavirus antibody.</li>
<li>Bridgeline Digital, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blin#NASDAQ">BLIN</a>) surged 70.2% to $2.1099 following Q2 results. Bridgeline Digital swung to earnings of $0.33 per share, versus a year-ago loss of $39.93 per share.</li>
<li>Torchlight Energy Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trch#NASDAQ">TRCH</a>) shares gained 63.6% to $0.4744 after dropping over 21% on Thursday.</li>
<li>Aurora Cannabis Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acb#NYSE">ACB</a>) climbed 39.8% to $9.28 after reporting a rise in its Q3 sales.</li>
<li>J. C. Penney Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jcp#NYSE">JCP</a>) gained 37.1% to $0.2673 after the company made a $17 million interest payment due May 7th, on the last day of its 5-day grace period, May 14th.</li>
<li>Esquire Financial Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/esq#NASDAQ">ESQ</a>) jumped 24.1% to $14.52.</li>
<li>Chesapeake Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chk#NYSE">CHK</a>) shares surged 23.6% to $10.77.</li>
<li>Alta Equipment Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/altg#NYSE">ALTG</a>) gained 22.1% to $5.06 after the company reported Q1 results.</li>
<li>Regional Management Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rm#NYSE">RM</a>) surged 21.6% to $14.61. BMO Capital upgraded Regional Management from Market Perform to Outperform and raised the price target from $14 to $29.</li>
<li>GeoPark Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gprk#NYSE">GPRK</a>) rose 18.4% to $7.98.</li>
<li>Glory Star New Media Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsmg#NASDAQ">GSMG</a>) gained 18% to $4.19.</li>
<li>AgroFresh Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfs#NASDAQ">AGFS</a>) jumped 17.6% to $2.4101.</li>
<li>Power REIT (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pw#NYSE">PW</a>) rose 17.4% to $18.78 after the company announced the acquisition of a 3 acre property in York County, Maine for $1,000,000 through a newly formed wholly owned subsidiary.</li>
<li>Reliv&#39; International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/relv#NASDAQ">RELV</a>) shares jumped 16.4% to $3.69 following Q1 results. Reliv&#39; International posted Q1 earnings of $0.36 per share, up from $0.13 per share in the year-ago period.</li>
<li>StoneMor Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ston#NYSE">STON</a>) shares rose 16.1% to $0.6790 after the company swung to a Q1 profit of $0.10 per share, versus a year-earlier loss of $0.59 per share.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) gained 15.5% to $3.995.</li>
<li>Oportun Financial Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oprt#NASDAQ">OPRT</a>) shares surged 13.5% to $6.82 after reporting an 18% rise in Q1 revenue.</li>
<li>Fortuna Silver Mines Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsm#NYSE">FSM</a>) gained 13.2% to $3.8050. Fortuna Silver Mines reported a Q1 net loss of $4.5 million.</li>
<li>Purple Innovation, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prpl#NASDAQ">PRPL</a>) shares climbed 12.8% to $12.93 after the company reported pricing of upsized secondary public offering of Class A common stock.</li>
<li>Aldeyra Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) jumped 12.8% to $4.2309.</li>
<li>Regis Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rgs#NYSE">RGS</a>) gained 12.2% to $9.09</li>
<li>Denny&#39;s Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/denn#NASDAQ">DENN</a>) rose 11.5% to $9.78 after the company reported better-than-expected Q1 earnings.</li>
<li>New Relic Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newr#NYSE">NEWR</a>) shares gained 11.3% to $64.89 after the company reported better-than-expected Q4 results.</li>
<li>Yield10 Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yten#NASDAQ">YTEN</a>) gained 11% to $5.37 after the company reported Q1 results. The company also secured regulatory permits for the US and Canadian Sites and announced plans for 2020 field test program in Camelina and Canola.</li>
<li>AgEagle Aerial Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uavs#NYSE">UAVS</a>) gained 9.5% to $1.39.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Cassava Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sava#NASDAQ">SAVA</a>) shares dipped 74.8% to $2.0450 after the company announced the results from its Phase 2b study of PTI-125 in Alzheimer&#39;s disease did not meet the primary endpoint.</li>
<li>Creative Realities, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crex#NASDAQ">CREX</a>) fell 33.3% to $2.87 after the company filed for a mixed shelf offering of up to $50 million. The company also reported Q1 sales results down from last year.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) dipped 30% to $1.57 after the company reported worse-than-expected Q1 results.</li>
<li>Synthesis Energy Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ses#NASDAQ">SES</a>) fell 28.5% to $2.0747. Synthesis Energy Systems received a notice from the Nasdaq Panel that it will suspend trading in company&rsquo;s stock as of May 18.</li>
<li>Super League Gaming, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slgg#NASDAQ">SLGG</a>) tumbled 22.9% to $3.1550 after the company posted a wider loss for its first quarter.</li>
<li>Applied DNA Sciences, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apdn#NASDAQ">APDN</a>) fell 20% to $12.17 after the company reported weaker-than-expected results for its second quarter. The company&rsquo;s shares jumped 71% on Thursday after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.</li>
<li>Co-Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/codx#NASDAQ">CODX</a>) shares fell 19.8% to $17.76 after reporting Q1 results.</li>
<li>ADDvantage Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aey#NASDAQ">AEY</a>) dipped 18.4% to $1.81 following Q2 results. Addvantage Technologies posted a Q2 loss of $1.41 per share.</li>
<li>NeoPhotonics Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nptn#NYSE">NPTN</a>) dropped 16.8% to $7.25.</li>
<li>NantKwest, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nk#NASDAQ">NK</a>) shares tumbled 16% to $4.34. Nantkwest announced plans for a Phase 2, randomized, open-label study to evaluate the efficacy and safety of a combination immunotherapy: NantKwest&#39;s PD-L1 t-haNK, ImmunityBio&#39;s N-803, and aldoxorubicin HCI plus standard of care, versus standard-of-care chemotherapy for first- and second-line treatment of locally advanced or metastatic pancreatic cancer.</li>
<li>Genfit SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnft#NASDAQ">GNFT</a>) fell 15.1% to $5.67 after dropping over 6% on Thursday.</li>
<li>U.S. Global Investors, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grow#NASDAQ">GROW</a>) dropped 14.6% to $1.7673 after reporting Q3 results.</li>
<li>Viad Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vvi#NYSE">VVI</a>) shares tumbled 13.6% to $14.39. Viad reported Q1 preliminary sales of $306 million.</li>
<li>Plus Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstv#NASDAQ">PSTV</a>) fell 13.2% to $1.85 following Q1 results.</li>
<li>IZEA Worldwide, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izea#NASDAQ">IZEA</a>) fell 13.2% to $0.6112 after the company reported weaker-than-expected Q1 results.</li>
<li>VectoIQ Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtiq#NASDAQ">VTIQ</a>) shares fell 13.1% to $22.42 after dipping 15% on Thursday.</li>
<li>AIM ImmunoTech Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aim#NYSE">AIM</a>) dipped 13.1% to $2.5538.</li>
<li>Inuvo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/inuv#NYSE">INUV</a>) fell 13% to $0.3450 after reporting a Q1 loss of $0.05 per share.</li>
<li>TESSCO Technologies Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tess#NASDAQ">TESS</a>) dipped 12.7% to $4.20.</li>
<li>Farfetch Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) fell 12% to $13.99 after the company reported worse-than-expected Q1 sales results.</li>
<li>Immunic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imux#NASDAQ">IMUX</a>) dropped 11.3% to $9.56.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttnp#NASDAQ">TTNP</a>) fell 11.2% to $0.3018.</li>
<li>Armstrong Flooring, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/afi#NYSE">AFI</a>) shares slipped 11% to $2.2450.</li>
<li>Hollysys Automation Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holi#NASDAQ">HOLI</a>) dipped 10.8% to $12.56 after reporting downbeat Q3 results.</li>
<li>SG Blocks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgbx#NASDAQ">SGBX</a>) shares fell 8.7% to $2.3250 after the company reported a wider Q1 loss.</li>
</ul>

Intraday Update

DENN

UAVS

50 Stocks Moving In Friday's Mid-Day Session

Reliv' International (NASDAQ:<a class="ticker" href="/stock/RELV#NASDAQ">RELV</a>) reported quarterly earnings of $0.360 per share. This is a 176.92 percent increase over earnings of $0.130 per share from the same period last year. The company reported $10.300 million in sales this quarter. This is a 8.54 percent increase over sales of $9.490 million the same period last year.

Reliv' International Q1 EPS $0.360 Up From $0.130 YoY, Sales $10.300M Up From $9.490M YoY

Reliv' International (NASDAQ:<a class="ticker" href="/stock/RELV#NASDAQ">RELV</a>) reported quarterly losses of $(0.29) per share. This is a 262.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $8.2 million in sales this quarter. This is a 11.98 percent decrease over sales of $9.316 million the same period last year.

Reliv' International Q4 EPS $(0.29) Down From $(0.08) YoY, Sales $8.2M Down From $9.316M YoY

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Reliv' International

Reliv' International (RELV) Forecast

Reliv' International (OTC:RELV) Stock, Quote.Headers.trade-ideas